#efferon

1 story

#biotech startup #blood purification #ce mark #fda approval #medical device #pediatric sepsis #startups #techcrunch disrupt 2026 #technology

Efferon's device targets pediatric sepsis
A startup selected for TechCrunch Disrupt 2026 has developed a blood purification device designed to save children from sepsis, a leading cause of childhood death.
TechCrunch · 1m